Як цитувати



Sheremet MI, Sydorchuk LP, Shidlovskyi VO, Bedenyuk AD. Research of prognostic markers of proliferation and apoptosis in patients with nodular goiters combined with autoimmune thyroiditis. Arch Balk Med Union 2016;51(4): 488-91.

Kazakov SP, Kushlinsky NY. The investigation of CD 95, P53, BCL-2 and Ki-67 markers in autoimmune thyroid pathology patients. First Joint Meeting of European National Societies of Immunology Under the auspices of EFIS and 16th European Congress of Immunology: ECI. 2006; Sept. 6-9, Paris, France: 547.

Sheremet МІ, Sydorchuk LP, Shidlovskyi VО, Bedenyuk AD, Popovych AI, Lazaruk OV. Fine needle biopsy in differential diagnosis of nodular goiter with autoimmune thyroiditis and differentiated thyroid cancers. Journal of Education, Health and Sport 2017; 7(4):701-6.

Sheremet MI, Sydorchuk LP, Shidlovskyi VO, et al. Remote results of hemithyroidectomy and their prognostication in patient with unilateral nodular goiter combined with autoimmune thyroiditis. Arch Balk Med Union 2018;53(1): 41-6.

Wienhold R, Scholz M, Adler JR, et al. The management of thyroid nodules: a retrospective analysis of health insurance data. Dtsch Arztebl Int. 2013;110(49): 827–34.

Sheremet MI, Sydorchuk LP, Shidlovskyi VO, et al. Influence of the CTLA-4 (rs231775) gene polymorphism on the degree of the thyroid gland enlargement in patients operated for nodular goiter secondary to autoimmune thyroiditis. Arch Balk Med Union 2017; 52(4):384-90.

Ahn HS, Kinm HJ, Welch HG, et al. Korea’s thyroid cancer epidemic-screening and overdiagnosis. N Engl J Med 2014;371(19):1765–67.

Diaconescu MR, Glod M, Costea I, Grigorovici M, Diaconescu S. Indications for surgery in thyroiditis. Chirurgia (Bucur). 2012;107(3):337-42.

Erdal M, Sahin M, Hasimi A, Uckaya G, Kutlu M, Saglam K. Trace element level-s in Hashimoto’s thyroiditis patients with subclinical hypothyroidism. Biol Trace Elem Res. 2008;123(1-3):1-7.

Nakahara M, Nagayama Y, Saitoh O, et al. Expression of immunoregulatory molecules by thyrocytes protects nonobesediabetic-H2h4 mice from developing autoimmune thyroiditis. Endocrinol. 2009;150(3):1545–1551.

Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS. Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. Journal of Interferon & Cytokine Research 2011;31(10): 721-31.

Guan LJ, Wang X, Meng S, et al. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 2015; 72(2): 160-5.

Sheremet MI, Shidlovskyi VO, Sydorchuk LP. Assessment of proliferation and apoptosis markers in patients with autoimmune thyroiditis. Journal of Education, Health and Sport 2016;6(1):179-188.

Rautureau GJ, Day CL, Hinds MG. Intrinsically disordered proteins in bcl-2 regulated apoptosis. Int J Mol Sci 2010;11(4):1808-24.

Kinnally KW, Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 2007;12(5):857-68.

Erdamar H, Demirci H, Yaman H, et al. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med. 2008;46(7):1004-10.

Chen AY, Bernet VJ, Carty SE, Davis TF, Ganky I, Inabnet WB III, Shaha AR. American Thyroid Association statement on optimal surgical management of goiter. Thyroid 2014; 24:181–89.

Randolph GW, Dralle H, Abdullah H, et al. Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope 2011; 121(Suppl 1):S1–16.

Chen Y, Sadow PM, Suh H, Lee KE, Choi JY, Suh YJ, Wang TS, Lubitz CC. BRAF (V600E) is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis. Thyroid 2016; 26(2):248–55.

Cho JW, Lee YM, Lee YH, Hong SJ, Yoon JH. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients. Clinical Endocrinology 2018; 89(1):100–109.

Haugen BR, Alexander EK, Bible KC, et al. Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.

Lee YM, Lee YH, Song DE, et al. Prognostic impact of further treatments on distant metastasis in patients with minimally invasive follicular thyroid carcinoma: verification using inverse probability of treatment weighting. World Journal of Surgery 2017;41:138–145.

Lee YM, Park JH, Cho JW, Hong SJ, Yoon JH. The definition of lymph node micrometastases in pathologic N1a papillary thyroid carcinoma should be revised. Surgery 2019; 165(3):652–656.

Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 2014;24(6):958–965.

Nath MC, Erickson LA. Aggressive variants of papillary thyroid carcinoma: hobmail, tall cell, columnar, and solid. Advances in Anatomic Pathology 2018;25(3):172–179.

Song E, Jeon MJ, Oh HS, et al. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma? European Journal of Endocrinology 2018;179(3):135–142.

Wreesmann VB, Nixon I J, Rivera M, et al. Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid 2015;25(5):503–508.

Khmelnitsky DC. Cytological and histological diagnosis of thyroid diseases: a guide. St. Petersburg, 2002:288.

Nikonenko AG, Bozhok YM. Patterns of papillary thyroid carcinoma cells analyzed in fine-needle aspiration smears may reveal changes in tumor cell behavior. Diagnostic Cytopathology, 2012 May;40 Suppl 1:E55-61.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.


Дані завантаження ще не доступні.

| Переглядів: 33 | Завантажень: 34 |